Crow Point Partners, LLC - FOAMIX PHARMACEUTICALS LTD ownership

Back to all holdings Add to watchlist

FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 66 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q4 2019. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.

Links
Filings
External links
Quarter-by-quarter ownership
Crow Point Partners, LLC ownership history of FOAMIX PHARMACEUTICALS LTD
ValueSharesWeighting
Q4 2019$341,000
+26.8%
103,816
+18.7%
0.53%
+1266.7%
Q3 2019$269,000
+195.6%
87,473
+127.7%
0.04%
+160.0%
Q2 2019$91,000–38,420–0.02%–
 Download
Other shareholders

There were no reported owners of FOAMIX PHARMACEUTICALS LTD in Q4 2019.

NameSharesValueWeighting ↓
View complete list of FOAMIX PHARMACEUTICALS LTD shareholders